Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@guru0to1](/creator/twitter/guru0to1)
"1/ Indias #pharma sector is poised to grow at X% CAGR till FY30 reaching $92B from $59.8B in FY25. Care Ratings cites strength in generics biosimilars and CDMO services as key growth drivers amid global trade shifts"  
[X Link](https://x.com/guru0to1/status/1979383507286638626) [@guru0to1](/creator/x/guru0to1) 2025-10-18T03:06Z XX followers, XX engagements


"1/ After muted quarters Indias top IT firms#Infosys #TCS #HCLTech & #Wiproshow signs of revival. Deal execution picked up client budgets normalized and AI-led transformation gained traction. The JulySept quarter marked cautious optimism across the board"  
[X Link](https://x.com/guru0to1/status/1979382004001951832) [@guru0to1](/creator/x/guru0to1) 2025-10-18T03:00Z XX followers, XXX engagements


"3/ In constant currency terms #HCLTech posted XXX% sequential growth Infosys XXX% TCS XXX% and Wipro 0.3%. The pivot to GenAI data analytics & cloud modernisation is helping firms sustain growth amid macro uncertainty. #TechRecovery #DigitalTransformation"  
[X Link](https://x.com/guru0to1/status/1979382009261687151) [@guru0to1](/creator/x/guru0to1) 2025-10-18T03:00Z XX followers, XX engagements


"4/ TCS saw a XXX% revenue rise aided by faster ramp-ups and better execution. Margins expanded to XXXX% but net profit dipped XXX% due to a one-time restructuring charge. Total contract value hit $10B up from $9.4B. #TCS #ITDeals #DigitalInfra"  
[X Link](https://x.com/guru0to1/status/1979382012059197499) [@guru0to1](/creator/x/guru0to1) 2025-10-18T03:00Z XX followers, XX engagements


"5/ Infosys raised its lower-end CC growth guidance to X% keeping the upper range at X% and margin guidance at 2022%. Operating margin rose XX bps to XX% backed by better utilisation and cost control. #Infosys #AIExecution #TechEarnings"  
[X Link](https://x.com/guru0to1/status/1979382015070814614) [@guru0to1](/creator/x/guru0to1) 2025-10-18T03:00Z XX followers, XX engagements


"7/ Wipro posted a XXX% revenue rise to 22697 crore but profit fell XXX% to 3246 crore. Large deal bookings hit $4.7B with $2.9B in new contracts. Cost-optimisation and vendor consolidation continue to drive business. #Wipro #ITDeals #Efficiency"  
[X Link](https://x.com/guru0to1/status/1979382020670148626) [@guru0to1](/creator/x/guru0to1) 2025-10-18T03:00Z XX followers, XX engagements


"1/ #Zepto has closed a $450M funding round led by CalPERS pushing its valuation to $7Bup from $5B last Nov. With $900M net cash in bank the quick commerce player is now among Indias most well-capitalised startups. #StartupFunding #QuickCommerce"  
[X Link](https://x.com/guru0to1/status/1979382729486520802) [@guru0to1](/creator/x/guru0to1) 2025-10-18T03:03Z XX followers, XX engagements


"2/ Despite the US imposing XXX% tariffs on branded & patented imports Indian pharma remains insulated. Thats because 9095% of exports are low-cost generics which arent covered under the new tariff regime. #GenericDrugs #TradePolicy"  
[X Link](https://x.com/guru0to1/status/1979383510533099699) [@guru0to1](/creator/x/guru0to1) 2025-10-18T03:06Z XX followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@guru0to1 "1/ Indias #pharma sector is poised to grow at X% CAGR till FY30 reaching $92B from $59.8B in FY25. Care Ratings cites strength in generics biosimilars and CDMO services as key growth drivers amid global trade shifts"
X Link @guru0to1 2025-10-18T03:06Z XX followers, XX engagements

"1/ After muted quarters Indias top IT firms#Infosys #TCS #HCLTech & #Wiproshow signs of revival. Deal execution picked up client budgets normalized and AI-led transformation gained traction. The JulySept quarter marked cautious optimism across the board"
X Link @guru0to1 2025-10-18T03:00Z XX followers, XXX engagements

"3/ In constant currency terms #HCLTech posted XXX% sequential growth Infosys XXX% TCS XXX% and Wipro 0.3%. The pivot to GenAI data analytics & cloud modernisation is helping firms sustain growth amid macro uncertainty. #TechRecovery #DigitalTransformation"
X Link @guru0to1 2025-10-18T03:00Z XX followers, XX engagements

"4/ TCS saw a XXX% revenue rise aided by faster ramp-ups and better execution. Margins expanded to XXXX% but net profit dipped XXX% due to a one-time restructuring charge. Total contract value hit $10B up from $9.4B. #TCS #ITDeals #DigitalInfra"
X Link @guru0to1 2025-10-18T03:00Z XX followers, XX engagements

"5/ Infosys raised its lower-end CC growth guidance to X% keeping the upper range at X% and margin guidance at 2022%. Operating margin rose XX bps to XX% backed by better utilisation and cost control. #Infosys #AIExecution #TechEarnings"
X Link @guru0to1 2025-10-18T03:00Z XX followers, XX engagements

"7/ Wipro posted a XXX% revenue rise to 22697 crore but profit fell XXX% to 3246 crore. Large deal bookings hit $4.7B with $2.9B in new contracts. Cost-optimisation and vendor consolidation continue to drive business. #Wipro #ITDeals #Efficiency"
X Link @guru0to1 2025-10-18T03:00Z XX followers, XX engagements

"1/ #Zepto has closed a $450M funding round led by CalPERS pushing its valuation to $7Bup from $5B last Nov. With $900M net cash in bank the quick commerce player is now among Indias most well-capitalised startups. #StartupFunding #QuickCommerce"
X Link @guru0to1 2025-10-18T03:03Z XX followers, XX engagements

"2/ Despite the US imposing XXX% tariffs on branded & patented imports Indian pharma remains insulated. Thats because 9095% of exports are low-cost generics which arent covered under the new tariff regime. #GenericDrugs #TradePolicy"
X Link @guru0to1 2025-10-18T03:06Z XX followers, XX engagements

creator/twitter::1118902222924816385/posts
/creator/twitter::1118902222924816385/posts